Peer-reviewed veterinary case report
Long-term inhaled budesonide helps cats with asthma and bronchitis
By Galler, A et al.·Published in The Journal of small animal practice·2013·Department for Companion Animals and Horses·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Inhaled budesonide therapy in cats with naturally occurring chronic bronchial disease (feline asthma and chronic bronchitis).
- Species:
- cat
Plain-English summary
A group of cats with asthma and chronic bronchitis were treated with inhaled budesonide, a medication that helps reduce inflammation in the airways. Out of 43 cats, 23 continued the treatment for more than two months and showed significant improvement in their breathing. While some cats experienced a mild suppression of a hormone-regulating system, none showed any noticeable side effects from the medication. Overall, inhaled budesonide was well tolerated and helped many cats breathe easier.
People also search for: cat asthma treatment · inhaled medication for cats · chronic bronchitis in cats · budesonide for feline asthma
Abstract
OBJECTIVES: To describe the long term use of inhaled budesonide in cats with naturally occurring asthma and chronic bronchitis and to measure its effects. METHODS: Owners of 43 cats diagnosed with asthma or chronic bronchitis, which had been prescribed 400 µg of inhaled budesonide twice daily, were contacted and information was retrieved by a questionnaire. Nineteen cats still receiving inhaled budesonide after more than 2 months were re-evaluated clinically and underwent barometric whole body plethysmography and adrenocorticotropic hormone-stimulation testing. RESULTS: In 20 of the cats, therapy had been withdrawn by the owners. Cats (n=23) still receiving inhaled budesonide improved clinically and 19 cats that were reevaluated had significantly lower basal PENH (P=0·048) and higher PCPenh300 (P=0·049) values than before treatment. Corticosteroid-induced side effects were not observed in any cats but hypothalamic-pituitary-adrenal axis suppression was detected in 3 of 15 cases. CLINICAL SIGNIFICANCE: Treatment with inhaled budesonide was well tolerated, resulting in improvement of clinical signs and barometric whole body plethysmography parameters. Although inhaled budesonide therapy was found to cause suppression of the hypothalamic-pituitary-adrenal axis in some cats, no cats showed clinical signs attributable to corticosteroid side effects.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/24000786/